Marcus, R.; Ferri-Borgogno, S.; Hosein, A.; Foo, W.C.; Ghosh, B.; Zhao, J.; Rajapakshe, K.; Brugarolas, J.; Maitra, A.; Gupta, S.
Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma. Cancers 2021, 13, 5709.
https://doi.org/10.3390/cancers13225709
AMA Style
Marcus R, Ferri-Borgogno S, Hosein A, Foo WC, Ghosh B, Zhao J, Rajapakshe K, Brugarolas J, Maitra A, Gupta S.
Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma. Cancers. 2021; 13(22):5709.
https://doi.org/10.3390/cancers13225709
Chicago/Turabian Style
Marcus, Rebecca, Sammy Ferri-Borgogno, Abdel Hosein, Wai Chin Foo, Bidyut Ghosh, Jun Zhao, Kimal Rajapakshe, James Brugarolas, Anirban Maitra, and Sonal Gupta.
2021. "Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma" Cancers 13, no. 22: 5709.
https://doi.org/10.3390/cancers13225709
APA Style
Marcus, R., Ferri-Borgogno, S., Hosein, A., Foo, W. C., Ghosh, B., Zhao, J., Rajapakshe, K., Brugarolas, J., Maitra, A., & Gupta, S.
(2021). Oncogenic KRAS Requires Complete Loss of BAP1 Function for Development of Murine Intrahepatic Cholangiocarcinoma. Cancers, 13(22), 5709.
https://doi.org/10.3390/cancers13225709